Johnson & Johnson appoints Pat Smallcombe to company group chairman, EMEA consumer


Johnson & Johnson Consumer has announced the appointment of Pat Smallcombe to the position of company group chairman, Europe, Middle East, Africa (EMEA)effective 1 January 2019. Smallcombe will have overall leadership for the EMEA Consumer business driving growth and market share for some of the region’s best-loved brands such as JOHNSON’S Baby, LE PETIT MARSEILLAIS, NEUTROGENA, and LISTERINE.

Smallcombe most recently served as president, One J&J Southeast Asia (SEA), where he was responsible for Johnson & Johnson’s total SEA footprint, covering Janssen, Medical Device, and consumer businesses.

An experienced and global leader, Smallcombe has previously held roles in Johnson & Johnson Asia Pacific, EMEA and North America, joining Johnson & Johnson in 2006 as part of the Pfizer Consumer Health (PCH) acquisition. 

Smallcombe began his career as a pharmaceutical research scientist and formerly served as President of the Proprietary Association of Great Britain (PAGB), with a key goal to shape the healthcare marketplace and empower patient self-care. He also has prior experience as Managing Director of Pfizer Consumer Healthcare and Vice President, Research & Development Europe.

Jorge Mesquita, executive vice president worldwide chairman, consumer said: “I am so pleased to have Pat re-join the EMEA region. His reputation in the company and industry alike is second to none and his experience and dedication in nurturing talent and building high performing teams provide a solid foundation for the region to deliver growth across the region.”